GE HealthCare Technologies Inc. $GEHC Shares Acquired by Impax Asset Management Group plc

Impax Asset Management Group plc boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 76.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 15,434 shares of the company’s stock after buying an additional 6,689 shares during the quarter. Impax Asset Management Group plc’s holdings in GE HealthCare Technologies were worth $1,143,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Calamos Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 0.7% during the 2nd quarter. Calamos Advisors LLC now owns 109,512 shares of the company’s stock worth $8,112,000 after acquiring an additional 738 shares in the last quarter. Police & Firemen s Retirement System of New Jersey lifted its holdings in shares of GE HealthCare Technologies by 5.7% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 69,856 shares of the company’s stock valued at $5,174,000 after purchasing an additional 3,779 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of GE HealthCare Technologies by 2.0% in the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock valued at $881,060,000 after purchasing an additional 231,302 shares during the period. Wealth Alliance LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $203,000. Finally, Mitsubishi UFJ Trust & Banking Corp increased its stake in GE HealthCare Technologies by 4.2% in the 2nd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 214,988 shares of the company’s stock worth $15,924,000 after purchasing an additional 8,569 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $73.15 on Friday. The firm has a 50 day simple moving average of $75.15 and a 200 day simple moving average of $73.68. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The stock has a market cap of $33.32 billion, a P/E ratio of 15.11, a P/E/G ratio of 2.78 and a beta of 1.13. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same quarter in the prior year, the business earned $1.14 EPS. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

Analysts Set New Price Targets

GEHC has been the subject of a number of analyst reports. Wells Fargo & Company reduced their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Finally, Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.